Precision medicine is a field of healthcare that deals with the treatment and prevention of diseases. It takes into consideration the individual characteristics of patients such as gene variability, environment, lifestyle, response to treatment, etc. The emerging field of precision medicine is based upon the idea that certain conditions (like cancer and heart diseases) are not similar in all individuals and therefore require a different treatment approach in every patient. Medical precision is essential for making healthcare more precise, predictable, powerful, and customized for every patient. Therefore, precision for medicine is one of the promising approaches for tackling diseases that have so far evaded effective treatments or cures.
Know anyone building innovative solutions that belong in this 'Precision Medicine'?
A neoteric breakthrough in Precision Medicine has been acclaimed as the steppingstone in disease prediction and prevention strategies. This integral change in our approach to medication therapy has federal efforts in developing the ‘’Hyperindividualised’’ therapy while taking into account the genetic patterns, drug responses, lifestyle and cultural environment. The substantial research in disease treatment strategies have contributed to developing target drugs, study of novel biomarkers in disease diagnosis, regenerative medicine leading to customized therapeutic approaches. Precision Medicine will not only have an impact on targeted treatment delivery but the prospect of studying the biological complexity of disorders associated with high mortality rate and cost-efficient treatment plans.
MarketsandMarkets is delighted to announce its Precision Medicine Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. The conference will assimilate diverse sessions on Comprehensive Overview of Precision Medicine, Novel horizons in biomarker strategies, Current Multi Omics analysis, Artificial Intelligence and Machine Learning, Gene expression Profiling in Precision Medicine, Contributions of Tissue engineering and Regenerative Medicine in target drug discovery. The event encompasses networking sessions, panel discussions, solutions, and services catering to precision medicine. The conference will constellate a full spectrum of experts, leaders, and stakeholders to share a board prospective the novel research and development in Precision Medicine.
The Personalized medicine will enlighten the world with recent advances in personalized medicine and Novel research and inculcate new ideas about Novel health. Moreover, this personalized medicine Conferences provides the participants a great networking with peers. Internationally prominent speakers, the novel techniques, and the modern updates in the personalized medicine. Fields are the unique attributes of this conference. Personalized medicine symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about personalized medicine and Novel Therapies. Personalized Medicine 2022 anticipates participants around the globe with thought-provoking Keynote lectures, Oral, Young Researcher Forum and Poster presentations with Exhibition. The attending delegates include Editorial Board Members of related Journals.
The 6th Annual Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care will focus on the use of liquid biopsy in cancer, covering the latest updates on the use of these techniques across various malignancies. In general, liquid biopsy refers to sampling from the peripheral blood and other compartments in the body, isolating circulating tumor cells, cell-free DNA, and other materials to perform noninvasive genetic testing that may inform treatment decision-making. Understanding the applications of these technologies, as well as the data informing their use, is critical for practicing oncologists.
Precision medicine is deeply transforming healthcare by tailoring care precisely to the individual. This exacting approach to care is leveraging data, genomics, and increasing interoperability to help clinicians identify the most appropriate, cost-effective treatments, and even spot previously undetected causes of disease. The aim of the “Precision Medicine Webinar” is to gather senior level executives from pharmaceutical and biotechnology companies and discuss during this full-day conference the current trends and challenges in the precision medicine industry.
The intersection of precision medicine and public health is a new and developing field called precision public health. Protecting and enhancing people's and their communities' health is the main goal …
The Personalized medicine will enlighten the world with recent advances in personalized medicine and Novel research and inculcate new ideas about Novel health. Moreover, this personalized medicine Conferences provides the participants a great networking with peers. Internationally prominent speakers, the novel techniques, and the modern updates in the personalized medicine. Fields are the unique attributes of this conference. Personalized medicine symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about personalized medicine and Novel Therapies.
Partnership will enable member orthopedic surgeons to identify potential drug-gene interactions to improve the patient experience and outcomes
RALEIGH, N.C. and LAKE FOREST, Calif. – May 24, 2021 – US …
As AGBT Precision Health enters our 6th year we continue to focus on technologies, implementation, and major research breakthroughs. This event is for leading genomic researchers, healthcare professionals, and healthcare industry stakeholders. We bring together practitioners and innovators at the interface of genomics, medicine, and health to usher in a new era of precision medicine. Our aim is to pass the torch from pioneering researchers and developers of genome technologies to first movers in healthcare who are establishing standards of care and cutting-edge applications for genome technology in everyday clinical practice.
INVEST PharmaTech is a virtual executive summit where established biopharma companies gather with health tech and digital health innovators to transform the industry. PharmaTech is the next chapter of the biopharma industry as it aims to leverage digital innovations for a transformation that will take them to achieve even more success in the future and transform the lives of patients.
MedCity INVEST PharmaTech will bring together regional and national stakeholders across established biotech and pharma companies and link them with health tech and digital health innovators virtually to enable conversations around AI and drug discovery, virtual clinical trials and digital twins, patient engagement and medication adherence, as well as digitizing manufacturing, operations and much more.
Cambridge Healthtech Institute’s Seventeenth Annual Biomarkers & Precision Oncology World Congress is the longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. Since 2004, the Congress has emerged as the leading annual meeting where big pharma and biotech drive innovation and collaboration in clinical and translational biomarkers, precision medicine and companion diagnostics, precision oncology and immuno-oncology biomarkers, liquid biopsy, spatial biology and single-cell analysis. Please join us for comprehensive scientific coverage and unparalleled networking opportunities at the in-person Biomarkers & Precision Oncology World Congress 2022 in Boston.
The 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference scheduled to be held on 16th - 17th June 2022 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.
Precision medicine is focused on the idea that a particular disease causes different physical symptoms in different individuals depending on their genome structure, lifestyle, and environmental factors. Biomarkers are the focal point of advances in Precision Medicine. The knowledge of the genetic and genomic architecture of disorders has advanced dramatically in recent years.
This inaugural Miami Precision Medicine Conference will highlight the best of technology, science, and oncology practice to advance the future of cancer care. CME topics will include:
Next-Generation Sequencing, Liquid Biopsies and Molecularly Driven Clinical Trials
Artificial Intelligence for Precision Medicine in 2022
Facing Rare and Common Tumor Types in Adults & Children: Precision Medicine Opportunities
New Era of Hope for Patients and Patient Advocates: Potentially Life-Saving Molecularly-Targeted Therapies
Precision medicine emerged to prominence over the last decade with a major impact on outcomes, allowing for personalized cancer treatments. The speed of scientific breakthroughs in precision medicine is leading to groundbreaking therapies. Novel Artificial Intelligence (AI) engines can potentially help to identify patterns and allow teams to uncover innovative strategies for specific cancers and individual patient populations. Today more than ever before, physician-scientists working with patients need real-time information aimed at creating an improved, value-based survivorship.
The first Miami Precision Medicine (MPM) international conference will bring together diverse experts in the field to share their knowledge and approaches in moving precision medicine towards routine practice. The course will examine the treatment landscape for various cancer types based on published and emerging data. An interdisciplinary molecular tumor board case discussion will illustrate the role of genomic alterations in selecting targeted treatments as well as present relevant precision medicine clinical trials.
Patients and advocacy groups will have an opportunity to share their insight, learn about promising clinical trials and partner with physicians to develop new strategies tailored to their specific needs. We aim to identify barriers to precision medicine, to promote and facilitate awareness, education and equity in precision medicine cancer care.
PrecisionMed Expo Dubai 2022provides a unique opportunity for those developing personalised healthcare solutions from across the globe to do business with the key healthcare decision-makers in the Gulf and Middle East region.
Growing populations, rising life expectancy and changes in lifestyle are leaving a healthcare burden for governments in the Gulf region, they have an urgent need to find smart approaches to tackle the medical needs of their populations.
Connect with healthcare providers & laboratories, distributors, investors, research bodies & government partners to grow your presence in the fastest growing market.
Over the past 28 years, the Tri-Conference has served as the leading international meeting place for the precision medicine community. As the world faces the challenges from the pandemic recovery, Cambridge Healthtech Institute once again takes the leadership role of bringing together the life science community at the TRI-CON 2022. Join thousands of international thought leaders in-person and/or virtually to discuss the latest research and technologies in precision medicine and precision health; innovation in point-of-care and molecular diagnostics and market access strategies; advanced diagnostics for COVID-19 and other infectious diseases; precision oncology diagnostics and therapeutics; liquid biopsy and minimal residual disease testing; biomarkers and companion diagnostics; and new technologies for spatial multi-omic analysis. Come to sunny San Diego for the in-person networking you’ve come to expect from the Tri-Conference; or join us virtually from the comfort of your home or office for online networking, the cutting-edge scientific program, and convenient on-demand viewing.
The Precision Medicine World Conference Silicon Valley (PMWC 2022) brings together executives and managers from Pharma and Diagnostic companies and Biotech. The Precision Medicine World Conference Silicon Valley (PMWC 2022) covers topics such as:
3rd Generation Sequencing
Single-cell Proteomic Analysis
Therapeutic Vaccines in Chronic Disease
Evolution of Translational Omics
Breast Cancer Genome
Diabetes & the Quantified Self
The role of treatment decision support in personalized cancer therapy
The 20th Precision Medicine World Conference (PMWC) will take place at the Pittsburgh Marriott City Center on September 23 and 24, 2021 in partnership with the University of Pittsburgh and UPMC. This city of steel has re-emerged as the city of Eds and Meds with nationally recognized universities and healthcare institutions. PMWC 2021 Pittsburgh brings together leading researchers to showcase practical content that helps close the knowledge gap among different sectors, thereby catalyzing cross-functional fertilization and collaboration to benefit both our valued partners and PMWC attendees.
Since 2009, the diagnostics community has united at Next Generation Dx Summit to discuss trendsetting developments, milestones, challenges, and opportunities in the industry. A decade later, the diagnostics industry has paved the path to the precision medicine era with the tremendous advancement in rapid and non-invasive testing, cancer detection and monitoring, and expanding applications of clinical sequencing.
This webinar showcases the innovative use of multiplexed immunofluorescence and subsequent imaging, revealing a vast potential for precision medicine: to quickly identify the right treatment for the individual patient, and limit or prevent late-stage clinical trial failures.
Attend the July 22 CPT® virtual meeting to discuss improving access and reducing burdens associated with genetic testing and precision medicine. Stakeholders will explore strategies to improve access and reduce the burden associated with genetic testing and precision medicine. Among other topics, strategies to evolve coding for genetic tests and what is needed beyond coding to overcome communication gaps will be discussed.
As much as precision medicine impacts cancer diagnosis and treatment today, it will be even more prominent in the future.
During the past 25 years as a medical oncologist, I have had the privilege of …
The SMART Precision Cancer Medicine app is based on the open-source SMART platform and communicates via FHIR, a new and promising HL7 standard. The app can function with any EHR system supporting the …
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our